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ETTERS TO THE EDITOR
CGitis in children other  with  suppurative  lymphadenitis  (exeresis  during  sup-
puration  phase).  Two  others  (suppurative  lymph-nodes)  had
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ear  Editor:
he  bacille  Calmette-Guérin  (BCG)  vaccine  is  a  live-virus
accine  with  attenuated  strains  of  Micobacterium  bovis,1,2
urrently  reaching  >80%  of  infants  in  countries  such  as
ortugal2 (97%  coverage  in  20112)  where  it  is  part  of  the
hildhood  immunization  programme.1 Adverse  effects  are
are  and  mostly  include  local  reactions  --  lymphadenitis
s  the  most  common  event,1,3,4 characterized  by  ipsilat-
ral  regional  lymph  nodes  enlargement  (nonsuppurative
r  suppurative),  2--8  months  after  vaccination.  There  is
o  consensus  about  the  best  treatment  for  lymphadeni-
is.
From  2010  to  2012,  4209  children  were  born  in  Vila
ova  Gaia,  of  which  4059  received  BCG  vaccine  and  4
ases  of  BCGitis  occurred  in  our  center  --  3  were  boys
nd  none  had  immunity  disorders  or  known  family  dis-
ases.  In  all  of  them,  nodal  involvement  was  ipsilateral
o  BCG  administration,  without  associated  symptoms  or
hysical  examination  abnormalities  and  happened  less
han  1  year  after  vaccination  (1--10  months).  One  child
ad  persistent  non-suppurative  lymphadenitis  and  three
eveloped  suppurative  disease  (1--3  months  after  node
nlargement)  --  Fig.  1.  Two  children  had  lymph-nodes  sur-
ical  exeresis  --  one  with  persistent  axillary  lymph-node
aspirative  biopsy  positive  for  Micobacterium  bovis)  and
Figure  1  Left  axillary  lymphadenitis.
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ith  complete  ﬁstulae  resolution  for  2--9  months  (without
eing  submitted  to  surgery,  needle  aspiration  or  antibi-
tics).
Our  rate  of  lymphadenitis  is  lower  than  those  presented
n  previous  studies3 --  early  vaccination  is  associated  with  a
ower  risk3 and  the  lower  the  dose  administered,  the  lower
he  risk  of  adverse  events3 --  we  had  0.05  mL  administered
t  birth.2 The  nurses’  experience  does  not  seem  to  affect
he  outcome3 but  it  could  not  be  evaluated  in  our  con-
ext.
The  nonsuppurative  form  usually  has  a  benign  clini-
al  course.  The  suppurative  form  is  characterized  by  a
uppurative  material  collection  that  can  rupture  with  per-
istent  caseous  discharge  and  wound  healing  taking  several
onths  -- secondary  bacterial  infection,  scarring  or  keloid
ormation  are  common.  Our  incidence  of  suppurative  lym-
hadenitis  is  similar  to  worldwide  data  --  30--80%.1 The
isk  of  suppuration  is  higher  in  younger  ages  and  in  those
ho  rapidly  develop  BCGitis5 --  our  suppurative  cases
eveloped  lymphadenitis  less  than  4  months  after  being  vac-
inated.
There  is  no  consensus  about  the  management  of  BCGitis
ut  treatment  is  not  usually  necessary  for  local  reactions4
nd  no  clear  beneﬁt  of  active  treatment  (pharmacologic
reatment,  needle  aspiration  or  surgical  excision)  over
xpectant  attitude4 was  found,  although  some  studies  advise
spiration  or  surgery  to  reduce  healing  time  and  adverse
osmetic  effects.4,5 Although  two  of  our  children  had  sponta-
eous  drainage  without  medical  or  surgical  treatment,  none
ad  sequelae.
Management  of  these  cases  should  consider  the  risk  of
nvasive  procedures  versus  the  length  of  time  for  resolution
nd  the  cosmetic  effects  of  conservative  measures.
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Lung volumes in the
pathogenesis of obstructive
sleep apnea
Volumes pulmonares na patogénese de apneia
obstrutiva do sono
To  the  Editor:
Obstructive  sleep  apnea  (OSA)  is  a  complex  disorder  charac-
terized  by  recurrent  episodes  of  upper  airway  obstruction.
Obstructive  events  occur  at  the  level  of  the  pharynx  and
there  are  many  factors  which  contribute  to  its  collapsibility.
It  has  been  suggested  that  reduced  end-expiratory  lung  vol-
umes  may  play  a  role.1 However  it  is  not  clear  whether,  and
to  what  extent,  lung  volumes  inﬂuence  obstructive  events
snoring  and  excessive  sleepiness,  were  examined  with  home
or  laboratory  polysomnography  and  performed  static  and
dynamic  spirometry.  Apnea-hypopnea  index  (AHI),  oxygen
desaturation  index  (ODI)  and  minimal  oxygen  desaturation
(mO2)  were  evaluated  in  relation  to  patient  lung  volumes.
A  total  of  75  subjects  (47  males,  aged  54.4  ±  12.3,  BMI
30.9  ±  4.7  kg/m2)  were  evaluated,  50  had  OSA,  8  severe
(AHI  >  30/h)  and  14  moderate  (AHI  >  15/h).  None  had  a
history  of  lung  disease.  Age,  weight,  BMI  and  neck  cir-
cumference  were  signiﬁcantly  higher  in  the  OSA  group.
There  was  no  signiﬁcant  difference  in  the  lung  volumes
between  the  two  groups.  However,  in  the  moderate/severe
OSA  patients,AHI  correlated  with  expiratory  reserve  volume
(ERV),  airway  resistance  (Raw)  and  BMI;  mO2  correlated
with  functional  residual  capacity  (FRC)  and  BMI  (Table  1).
In  regression  analysis,  BMI,  FRC  and  ERV  were  found  to  be
associated  with  AHI  and/or  mO2,  but  only  ERV  was  found  toand  oxygen  desaturations  independently  of  other  factors.
To  ﬁnd  answers  to  this,  all  patients  evaluated  in  a  sleep
consultation  unit,  over  a  6-month  period,  with  complaints  of
Table  1  Correlation  and  regression  analysis  of  OSA  variables  with
Patients’  parameters  AHI  
Spearmann’s
correlation
Regressio
analysis
R  p-Value  Univariate  Mu
Age  (years)  0.129  (ns)  --  --  
BMI (kg/m2)  0.571  0.006  0.042  (ns
Neck circumference  (cm)  0.04  (ns)  --  --  
Abdominal cir.  (cm)  0.255  (ns)  --  --  
Epworth’s score  0.163  (ns)  --  --  
FEV1 (l)  −0.287  (ns)  --  --  
FVC (l)  −0.407  (ns)  --  --  
TLC (l)  −0.426  (ns)  --  --  
RV (l)  −0.102  (ns)  --  --  
FRC (l)  −0.388  (ns)  --  --  
ERV (l)  −0.577  0.005  0.007  0.0
Raw 0.516  0.014  --  --  
BMI: body mass index; FEV1: forced expiratory volume in the 1st second
volume; FRC: forced residual capacity; ERV: expiratory reserve volume
b
a patients’  characteristics  and  lung  volumes.
mO2
n Spearmann’s
correlation
Regression
analysis
ltivariate  R  p-Value  Univariate  Multivariate
0.018  (ns)  --  --
)  −0.499  0.03  0.012  (ns)
−0.346  (ns)  --  --
−0.209  (ns)  --  --
−0.177  (ns)  --  --
−0.169  (ns)  --  --
0.029  (ns)  --  --
0.203  (ns)  --  --
0.279  (ns)  --  --
0.531  0.019  0.033  (ns)
015  0.262  (ns)  --  --
−0.026  (ns)  --  --
; FVC: forced vital capacity; TLC: total lung capacity; RV: residual
; Raw: airway resistance.
e  independently  related  to  AHI.
We  found  that  repeated  ahead  ERV,  FRC  and  BMI  were
ssociated  with  the  occurrence  of  obstructive  events.  This
